Discerning mild cognitive impairmentand alzheimer diseasefrom normal aging: Morphologic characterization based on univariate and multivariate models

Academic Radiology

Volumn 21, Issue 5, 2014, Pages 597-604

  Liao, Weiqi ^a   Long, Xiaojing ^a   Jiang, Chunxiang ^a   Diao, Yanjun ^a   Liu, Xin ^a   Zheng, Hairong ^a   Zhang, Lijuan ^a  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

Alzheimer disease; Brain morphology; Healthy aging; Mild cognitive impairment; Structural neuroimaging

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEMISPHERE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PRIORITY JOURNAL; TEMPORAL LOBE; THICKNESS; WHITE MATTER; ALGORITHM; AUTOMATED PATTERN RECOGNITION; BRAIN; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; DIFFERENTIAL DIAGNOSIS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

AGED; AGING; ALGORITHMS; ALZHEIMER DISEASE; BRAIN; COMPUTER SIMULATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PATTERN RECOGNITION, AUTOMATED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84897558049     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.12.001     Document Type: Article

References (49)

1. 2012 Alzheimer's disease facts and figures. Alzheimers Dement 2012, 8:131-168. Alzheimer's Association.
2. Ballard C., Gauthier S., Corbett A., et al. Alzheimer's disease. Lancet 2011, 377:1019-1031.
3. Sperling R.A., Karlawish J., Johnson K.A. Preclinical Alzheimer disease - the challenges ahead. Nat Rev Neurol 2013, 9:54-58.
4. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
5. Diagnostic and statistical manual of mental disorders (DSM-IV-TR) 2000, 147-151. American Psychiatric Association, American Psychiatric Press, Washington DC. 4th ed. - text revised.
6. Mattsson N., Rosen E., Hansson O., et al. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 2012, 78:468-476.
7. Buchhave P., Minthon L., Zetterberg H., et al. Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 2012, 69:98-106.
8. Thompson P.M., Hayashi K.M., de Zubicaray G., et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003, 23:994-1005.
9. Devanand D.P., Pradhaban G., Liu X., et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007, 68:828-836.
10. McEvoy L.K., Fennema-Notestine C., Roddey J.C., et al. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 2009, 251:195-205.
11. Misra C., Fan Y., Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009, 44:1415-1422.
12. Leung K.K., Barnes J., Ridgway G.R., et al. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage 2010, 51:1345-1359.
13. Ries M.L., Carlsson C.M., Rowley H.A., et al. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc 2008, 56:920-934.
14. Brown P.J., Devanand D.P., Liu X., et al. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry 2011, 68:617-626.
15. McDonald C.R., Gharapetian L., McEvoy L.K., et al. Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment. Neurobiol Aging 2012, 33:242-253.
16. Perrin R.J., Fagan A.M., Holtzman D.M. Multi-modal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 2009, 461:916-922.
17. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. Neuroimage 2000, 11:805-821.
18. Querbes O., Aubry F., Pariente J., et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 2009, 132:2036-2047.
19. Kochunov P., Thompson P.M., Coyle T.R., et al. Relationship among neuroimaging indices of cerebral health during normal aging. Hum Brain Mapp 2008, 29:36-45.
20. Shi F., Liu B., Zhou Y., et al. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies. Hippocampus 2009, 19:1055-1064.
21. Im K., Lee J.M., Seo S.W., et al. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease. Neuroimage 2008, 43:103-113.
22. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
23. Cummings J.L. Mini-Mental State Examination. Norms, normals, and numbers. JAMA 1993, 269:2420-2421.
24. Jack C.R., Bernstein M.A., Fox N.C., et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 2008, 27:685-691.
25. Fischl B., van der Kouwe A., Destrieux C., et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004, 14:11-22.
26. Desikan R.S., Segonne F., Fischl B., et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980.
27. Long X., Zhang L., Liao W., et al. Distinct laterality alterations distinguish mild cognitive impairment and Alzheimer's disease from healthy aging: statistical parametric mapping with high resolution MRI. Hum Brain Mapp 2013, 34:3400-3410.
28. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9:179-194.
29. Fischl B., Sereno M., Dale A. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999, 9:195-207.
30. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000, 97:11050-11055.
31. Long X., Liao W., Jiang C., et al. Healthy aging: an automatic analysis of global and regional morphological alterations of human brain. Acad Radiol 2012, 19:785-793.
32. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995, 57:289-300.
33. Evans M.C., Barnes J., Nielsen C., et al. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. Eur Radiol 2010, 20:674-682.
34. Nestor S.M., Rupsingh R., Borrie M., et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 2008, 131:2443-2454.
35. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
36. Dickerson B.C., Wolk D.A. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 2012, 78:84-90.
37. Seo S.W., Lee J.H., Jang S.M., et al. Neurochemical alterations of the entorhinal cortex in amnestic mild cognitive impairment (aMCI): a three-year follow-up study. Arch Gerontol Geriatr 2012, 54:192-196.
38. Mueller S.G., Schuff N., Yaffe K., et al. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2010, 31:1339-1347.
39. Adachi M., Kawakatsu S., Hosoya T., et al. Morphology of the inner structure of the hippocampal formation in Alzheimer disease. AJNR Am J Neuroradiol 2003, 24:1575-1581.
40. Poulin S.P., Dautoff R., Morris J.C., et al. Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatry Res 2011, 194:7-13.
41. Murphy E.A., Holland D., Donohue M., et al. Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls. Neuroimage 2010, 53:1310-1317.
42. Varon D., Loewenstein D.A., Potter E., et al. Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment. Dement Geriatr Cogn Disord 2011, 31:276-283.
43. Kochunov P., Mangin J.F., Coyle T., et al. Age-related morphology trends of cortical sulci. Hum Brain Mapp 2005, 26:210-220.
44. Li Y., Wang Y., Wu G., et al. Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features. Neurobiol Aging 2012, 33:415-427.
45. Donix M., Burggren A.C., Suthana N.A., et al. Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism. Neuroimage 2010, 53:37-43.
46. Toro R., Perron M., Pike B., et al. Brain size and folding of the human cerebral cortex. Cereb Cortex 2008, 18:2352-2357.
47. Fischl B., Rajendran N., Busa E., et al. Cortical folding patterns and predicting cytoarchitecture. Cereb Cortex 2008, 18:1973-1980.
48. van der Flier W.M., Pijnenburg Y.A., Fox N.C., et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE varepsilon4 allele. Lancet Neurol 2011, 10:280-288.
49. Koedam E.L., Lauffer V., van der Vlies A.E., et al. Early-versus late-onset Alzheimer's disease: more than age alone. J Alzheimers Dis 2010, 19:1401-1408.